LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

Tower Research Capital LLC (TRC)'s Holding History (CIK: 0001533421)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 24,269 Value ($000) $13 Avg Close Range
Q4 2024
Shares 19,490 Value ($000) $12 Avg Close Range
Q3 2024
Shares 8,257 Value ($000) $11 Avg Close Range
Q2 2024
Shares 24,861 Value ($000) $36 Avg Close Range
Q1 2024
Shares 4,014 Value ($000) $9 Avg Close Range
Q4 2023
Shares 33,041 Value ($000) $64 Avg Close Range
Q3 2023
Shares 29,184 Value ($000) $43 Avg Close Range
Q2 2023
Shares 3,671 Value ($000) $12 Avg Close Range
Q1 2023
Shares 10,687 Value ($000) $0 Avg Close Range
Q4 2022
Shares 3,037 Value ($000) $0 Avg Close Range
Q3 2022
Shares 8,546 Value ($000) $63 Avg Close Range
Q2 2022
Shares 7,919 Value ($000) $51 Avg Close Range
Q1 2022
Shares 8,665 Value ($000) $44 Avg Close Range
Q4 2021
Shares 8,841 Value ($000) $68 Avg Close Range
Q3 2021
Shares 2,481 Value ($000) $37 Avg Close Range